PFIZER U.S. Rx SALES AND MARKETING REORGANIZATION
Executive Summary
PFIZER U.S. Rx SALES AND MARKETING REORGANIZATION includes the creation of two groups aligned by therapeutic area. As part of the reorganization announced by Pfizer Jan. 11, the two groups have been assigned disease-specific areas of focus: the first has responsibility for cardiovascular diseases, allergic disorders and metabolic conditions; the second group is responsible for arthritis, mental health and infectious diseases.